09:10 : Shares of Protalix BioTherapeutics (PLX) gain 5.3% premarket after investor -
Shares of Protalix BioTherapeutics (PLX) gain 5.3% premarket after investors take a hard look at biotech drug names following the BMY-Inhibitex deal. The firm is aiming to develop a groundbreaking Gaucher disease treatment. ...